483 Suzhou Lixin Pharmaceutical May 2010

483 Suzhou Lixin Pharmaceutical May 2010

$119 - Not in Stock

FDA investigators audited the Suzhou Lixin Pharmaceutical - Suzhou, China facility and issued inspectional observations (via FDA 483) on 06 May 2010.

Product details

  • Category: Human Drugs
  • Inspection end: 06 May 2010
  • Location: Suzhou, China
  • FEI: 3008251350

Pre-Order Not Available